Google
×
Wikipedia
Iproniazid (Marsilid, Rivivol, Euphozid, Iprazid, Ipronid, Ipronin) is a non-selective, irreversible monoamine oxidase inhibitor (MAOI) of the hydrazine class. It is a xenobiotic that was originally designed to treat tuberculosis, but was later most prominently used as an antidepressant drug.
People also ask
Sep 11, 2007 · For the treatment of depression (originally intended to treat tuberculosis). Build, train, & validate predictive machine-learning models with structured ...
Treatments for depression · psychotherapy and psychotropic · medication, specifically · cognitive and behavioral responses to stressful life events while also ...
Missing: uses | Show results with:uses
Iproniazid is a drug that was initially investigated as an anti-tuberculosis medication but later found to have a mood-elevating effect.
Missing: uses | Show results with:uses
An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. It has also been used as an antitubercular agent.
Iproniazid was one of the first drugs associated with acute hepatitis. Reactions occurred in 1% of recipients and were often severe, with instances of fatal ...
Feb 27, 2021 · Dr. Kline first reported in 1957 the beneficial effects of iproniazid, a monoamine oxidase inhibitor, in the treatment of severe depression.
Missing: uses | Show results with:uses
By 1957 the ataractics or tranquilizers were widely used in the treatment of many mental diseases, including schizophrenia and the neuroses.
Iproniazid was administered to prevent or mitigate severe mental depression that often occurs in these patients. It was considered that the hazard of the ...
IPRONIAZID (MARSILID): ITS USE IN OFFICE TREATMENT OF DEPRESSION · 1. · 2. · 3. The rapid and sustained response of the patients who required ECT suggests that ...
Missing: uses | Show results with:uses